Embecta Corp. Announces Upcoming Investor Events
Embecta Corp. (“embecta”) (Nasdaq: EMBC), a leading global diabetes care company with a century-long history in insulin delivery, has revealed its participation in key investor events. These gatherings highlight the company's ongoing dedication to innovation in the field of diabetes care.
Participation in the 2024 Wells Fargo Healthcare Conference
During the 2024 Wells Fargo Healthcare Conference, management will conduct one-on-one investor meetings, providing a unique opportunity for personalized discussions about the company’s strategic direction and future plans.
Event Details
The meetings are set for September 4, 2024, at the Encore Boston Harbor Hotel. This event serves as an excellent platform for investors to engage directly with management and gain insights into Embecta’s objectives and vision.
Engagement at the 2024 Morgan Stanley 22nd Annual Global Healthcare Conference
Following the Wells Fargo event, management will host a fireside session at the 2024 Morgan Stanley 22nd Annual Global Healthcare Conference. This session is designed to encourage in-depth discussions regarding the company’s initiatives in diabetes management.
Fireside Chat Time and Location
The fireside chat is scheduled for September 5, 2024, at 2:35 p.m. Eastern Time, taking place at the Marriott Marquis in New York. Attendees can expect an insightful overview of the company’s strategic initiatives during this session.
Commitment to Diabetes Care
Embecta is committed to empowering individuals living with diabetes through its innovative solutions and services. With a workforce of over 2,000 employees worldwide, the company draws on its century-long expertise in insulin delivery to improve the lives of patients.
Innovative Solutions and Collaborations
As part of its mission, Embecta emphasizes innovation and collaboration. The company consistently strives to develop new technologies and enhance its existing product offerings, ensuring that diabetes care remains effective and accessible.
Stay Connected with Embecta
For those interested in keeping up with the latest news from Embecta, the company offers multiple channels for engagement. Stakeholders are encouraged to visit the investor relations section of the website for updates.
Website and Social Media Links
To learn more about Embecta and its initiatives, visit embecta.com. Additionally, you can follow Embecta on various social media platforms such as LinkedIn, Facebook, Instagram, and Twitter to stay informed.
Contacts for Media and Investor Relations
If you have media inquiries, please contact:
Christian Glazar
Sr. Director, Corporate Communications
Phone: 908-821-6922
For investor relations inquiries, please reach out to:
Pravesh Khandelwal
VP, Head of Investor Relations
Phone: 551-264-6547
For direct communication:
Email Media Relations: media.relations@embecta.com
Email Investor Relations: investor.relations@embecta.com
Frequently Asked Questions
What is the focus of the upcoming investor events?
The investor events will focus on discussing Embecta's strategic initiatives and advancements in diabetes care.
When will Embecta host one-on-one investor meetings?
Embecta will host one-on-one investor meetings on September 4, 2024, at the Wells Fargo Healthcare Conference.
Where is the Morgan Stanley Global Healthcare Conference being held?
The Morgan Stanley Global Healthcare Conference will take place at the Marriott Marquis in New York.
How can I follow updates from Embecta?
You can follow Embecta through their official website and various social media platforms for the latest news and updates.
Who can I contact for investor relations inquiries?
For investor relations inquiries, please contact Pravesh Khandelwal, VP, Head of Investor Relations at 551-264-6547.